I make a donation

Assessment of health status in patients with obstructive HCM treated with Mavcamten

Hypertrophic cardiomyopathy - Mavacamten - Health status

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

Bourses ACTION & PHRA 2022

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Prix de Recherche Pr Jean-Philippe COLLET

Publication presented by Julien MALVY

On June 15, 2021

Title: Mavacamten for treatment of symptomatric obstructive hyperthophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Reference: The Lancet, May 2021

Autres actualités

16/04/2024

The REDUCE-AMI Study

Beta-blockers - Myocardial infarction - Preserved ejection fraction

Know more

09/04/2024

Stellate Ganglion Block and Refractory Ventricular Arrhythmi...

SGB - Refractory Ventricular Arrhythmias - Electrical storm

Know more

02/04/2024

Etude T-PASS - Ticagrelor monotherapy vs DAPT 12

ACS - Dual anti platelet therapy - Ticagrelor - Aspirin

Know more